Treatment of ichthyosiform diseases with topically applied tazarotene: risk of systemic absorption.
Nguyen
Victoria
V
Cunningham
Bari B
BB
Eichenfield
Lawrence F
LF
Alió
Alessandra B
AB
Buka
Robert L
RL
D000287:Administration, Topical; D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003879:Dermatologic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007057:Ichthyosis / Q000188:drug therapy* / Q000378:metabolism*; D008297:Male; D009539:Nicotinic Acids / Q000008:administration & dosage* / Q000493:pharmacokinetics* / Q000627:therapeutic use; D012307:Risk Factors; D012176:Retinoids
D003879:Dermatologic Agents; D009539:Nicotinic Acids; C086827:tazarotene; D012176:Retinoids